Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.

Biotechnology

Health & Wellness

Amicus Therapeutics

Amicus Therapeutics' headquarters in Cranbury Township, NJ, United States

Bradley L. Campbell

Simon Harford

Ryan Graham

Patrik Florencio

David Clark

Diana Moore

Joon Chung

Heather Ramirez

Caroline Stockwell

Mike Keavany

Tiffany Patrick

Jeff Castelli

Assad Meyer

Jeffrey P. Castelli

Fermin Rivas

Richard Taylor

Sébastien Martel

Gwendolyn Whitney

Sam Pierre-Louis

Pat Osullivan

Jill Weimer

Jayne C. Gershkowitz

Robert Essner

Glenn P. Sblendorio

Margaret G. Mcglynn

Michael A. Kelly

Michael G. Raab

Eiry W. Roberts

Burke W. Whitman

Lynn D. Bleil

Craig A. Wheeler

The Leadership Team at Amicus Therapeutics drives the strategic direction and operational execution of the company, overseeing key areas such as research and development, regulatory affairs, compliance, and human resources. This diverse group of executives collaborates to advance the company's mission of developing innovative treatments for rare and orphan diseases, ensuring alignment between scientific goals, patient needs, and business objectives. Their collective expertise fosters a culture of compliance, innovation, and compassion within the organization.

Leadership Team

This department oversees clinical operations, medical affairs, and regulatory compliance to ensure the development and management of medical products.

Clinical Operations and Affairs

This department focuses on the development and implementation of strategies to support and improve outcomes for patients with rare diseases.

Rare Disease Management

The Clinical Research Team at Amicus Therapeutics is responsible for designing, planning, and overseeing clinical trials to evaluate the safety and efficacy of therapies for rare and orphan diseases. This multidisciplinary team collaborates with medical affairs professionals and patient support services to ensure that clinical development aligns with patient needs and regulatory standards, driving innovations that improve outcomes for individuals with these challenging conditions.

Clinical Research Team

The Supply Chain and Operations Team at Amicus Therapeutics is responsible for overseeing the end-to-end supply chain processes, ensuring the efficient procurement of materials, and managing logistics for the production of biotherapeutics. This team collaborates closely with various departments to optimize supply chain strategies, maintain regulatory compliance, and support clinical and commercial operations, all aimed at delivering treatments to patients with rare diseases.

Supply Chain and Operations Team

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

Amicus Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Affairs

Rare Disease Management

Clinical Research Team

Supply Chain and Operations Team

Executive Leadership

Offices

Amicus Therapeutics

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Affairs

Rare Disease Management

Clinical Research Team

Supply Chain and Operations Team

Executive Leadership

Offices

Related companies